Clinical Trial

Getting to Zero Among HHI MSM in the American South

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
This study will evaluate a status-neutral integrated strategy to improve access to and uptake of HIV prevention and treatment services for the highest HIV incidence (HHI) men who have sex with men (MSM) in participating communities. The ultimate goal is to establish a strategy to reduce HIV incidence among HHI MSM in the southern United States (US) by increasing the number of HHI MSM accessing prevention and treatment services, increasing uptake and use of pre-exposure prophylaxis (PrEP) among those living without HIV and increasing retention in care, and thus viral suppression, among those living with HIV.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2021-09-29; most recent amendment 2026-03-11.
Status change: Suspended → Enrolling by Invitation 2026-03-11
Status change: Enrolling by Invitation → Suspended 2025-03-13
Status change: Recruiting → Enrolling by Invitation 2023-05-15
Status change: Not Yet Recruiting → Recruiting 2022-08-25
Trial Details
NCT Number NCT05075967
Lead Sponsor HIV Prevention Trials Network
Collaborators: National Institute of Allergy and Infectious Diseases (NIAID)
Conditions HIV Infections
Enrollment 2,700 participants
Start Date 2025-12-10
Primary Completion 2028-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-13